Key Points
- Director Mitchell Austin Rudy bought 7,500 shares of Bonk on June 22 at an average price of $1.56, spending $11,700. After the purchase, he owned 73,341 shares, an 11.39% increase in his holdings.
- Rudy has been actively adding to his position, with additional buys on June 16, June 10, and April 9 totaling tens of thousands of shares. The recent cluster of purchases suggests continued insider confidence.
- Bonk’s stock has been under pressure, trading near $1.54 versus a 50-day average of $2.11 and a 200-day average of $3.03. Analysts currently rate the stock a Sell, and the company reported a quarterly loss with negative margins.
Bonk, Inc. (NASDAQ:BNKK - Get Free Report) Director Mitchell Austin Rudy acquired 7,500 shares of Bonk stock in a transaction that occurred on Monday, June 22nd. The stock was acquired at an average cost of $1.56 per share, for a total transaction of $11,700.00. Following the completion of the purchase, the director directly owned 73,341 shares of the company's stock, valued at $114,411.96. This represents a 11.39% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Mitchell Austin Rudy also recently made the following trade(s):
- On Tuesday, June 16th, Mitchell Austin Rudy bought 2,500 shares of Bonk stock. The stock was acquired at an average price of $1.32 per share, for a total transaction of $3,300.00.
- On Wednesday, June 10th, Mitchell Austin Rudy bought 12,000 shares of Bonk stock. The shares were acquired at an average cost of $1.37 per share, with a total value of $16,440.00.
- On Thursday, April 9th, Mitchell Austin Rudy bought 31,055 shares of Bonk stock. The stock was bought at an average cost of $2.82 per share, with a total value of $87,575.10.
Bonk Stock Performance
BNKK stock opened at $1.54 on Wednesday. The firm has a 50-day moving average price of $2.11 and a 200-day moving average price of $3.03. Bonk, Inc. has a 12 month low of $1.25 and a 12 month high of $46.90. The stock has a market capitalization of $12.32 million, a P/E ratio of -0.33 and a beta of 1.86.
Bonk (NASDAQ:BNKK - Get Free Report) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. The company had revenue of $0.79 million for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%.
Wall Street Analyst Weigh In
A number of analysts have weighed in on BNKK shares. Wall Street Zen cut shares of Bonk from a "hold" rating to a "sell" rating in a research note on Sunday. Weiss Ratings cut Bonk from a "sell (d-)" rating to a "sell (e+)" rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Bonk has a consensus rating of "Sell".
Check Out Our Latest Stock Analysis on BNKK
Hedge Funds Weigh In On Bonk
A number of hedge funds have recently modified their holdings of BNKK. State Street Corp acquired a new stake in Bonk in the fourth quarter valued at $33,000. Steward Partners Investment Advisory LLC acquired a new position in Bonk during the 4th quarter worth about $37,000. Jane Street Group LLC acquired a new position in Bonk during the 4th quarter worth about $96,000. Finally, Geode Capital Management LLC bought a new stake in shares of Bonk in the 4th quarter valued at about $128,000. Institutional investors and hedge funds own 12.55% of the company's stock.
About Bonk
(
Get Free Report)
Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
